Simple additive boosts arm surgery pain relief
NCT ID NCT07399691
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested whether adding dexamethasone to the standard numbing drug bupivacaine improves pain blocks for upper arm surgery. In 54 adults, the combination led to faster numbness and longer pain relief compared to bupivacaine alone. The approach aims to improve patient comfort and reduce the need for additional pain medication after surgery.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- dexamethasone added to bupivacaine
- What this could lead to
- If confirmed, this combination could provide longer-lasting pain relief after arm surgery, reducing the need for extra painkillers.
- What could go wrong
- This was a small, single-center study with only 54 participants. Results may not apply to all patients or surgeries, and the long-term safety of adding dexamethasone this way is not fully known.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
54 people
The number who actually took part.
- Started
-
Jan 2024
- Finished
-
Apr 2024
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
The study included 54 patients aged 18-60 years with ASA I and II who were scheduled for elective elbow, forearm, or hand surgery under ultrasound-guided supraclavicular bloc
- Ages
-
18 to 60 years
- Sex
-
Anyone
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: Aged 18-60 years with ASA I and II who were scheduled for elective elbow, forearm, or hand surgery under ultrasound-guided supraclavicular block. Exclusion Criteria: Patients who refused, used local anaesthetics other than bupivacaine, had multiple traumas, addition of another additive, bleeding disorders, patients diagnosed with chronic pain, cancer pain, local infection at the injection site, history of local anaesthetic allergy, patients with anxiety, and inability to comprehend or use the pain rating scale
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Bupivacaine are added.
Genom att skicka in godkänner du våra Användarvillkor
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Mohammed Gebi
Āsela, Ethiopia
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a common steroid stretch spinal anesthesia and keep surgery patients comfortable longer?
- Can a Nerve-Blocking injection prevent salivary complications after parotid surgery?
- Could a steroid injection double as a painkiller for brain surgery?
- Can a steroid outperform a standard antiemetic to stop Post-Surgery sickness?
- Can a simple wash of local anesthetic cut Post-Surgery pain and opioid use?
- A steroid-sparing strategy: could olanzapine curb chemo nausea without the metabolic toll?